You are viewing the public part of the archive. Login or request access to view more content.

Displaying 1-6 of 6 results
first frame of video
00:08:14

2012_96

XIX International AIDS Conference. Interview with Adeeba Kamarulzaman from the University of Malaya in Kuala Lumpur, Malaysia. She talks about the obstacles and possibilities of ending HIV and AIDS.

2012_96

first frame of video
00:13:04

2012_95

XIX International AIDS Conference in Washington D.C. Gottfried Hirnshall is Director of Department of HIV and Global Hepatitis Programme at the WHO. Here he talks about what needs to be done from a health policy perspective to end AIDS, and the role of WHO.

2012_95

first frame of video
00:03:37

2012_37

XIX International AIDS Conference. Matias Ostrowski from University of Buenos Aires is part of the CNIHR program lead by IAS and NIH. He is involved in basic research on the cell biology of HIV with the target of creating new ideas for drug development.

2012_37

first frame of video
00:13:19

2012_100

XIX International AIDS Conference. Sharon Lewin from Monash University in Melbourne discusses the possibilities of ending AIDS and scientific breakthroughs during the 30 years of the epidemic, for instance the discovery that some people are resistant to HIV.

2012_100

first frame of video
00:16:39

2008_82_02

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

2008_82_02

first frame of video
00:13:24

2008_68_04

XVII International AIDS Conference in Mexico City. Dr Daria Hazuda from MSD, who has been involved in antiretroviral drug development during the past 20 years, holds a presentation. She is also interviewed about leadership and the progress of ARV and vaccine development.

2008_68_04